Midwest Capital Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$284K Hold
236
– – 0.12% 50
2026
Q1
$218K Hold
236
– – 0.1% 53
2025
Q4
$254K Hold
236
– – 0.12% 46
2025
Q3
$180K Hold
236
– – 0.09% 54
2025
Q2
$184K Sell
236
-40
-14% -$31.1K 0.1% 51
2025
Q1
$228K Buy
276
+40
+17% +$33.3K 0.14% 49
2024
Q4
$182K Buy
+236
New +$195K 0.13% 53

Other funds holding LLY

Midwest Capital Advisors's LLY Position: Q2 2026 in Review

Midwest Capital Advisors held its Eli Lilly (LLY) position steady in Q2 2026 at 236 shares worth $284K. The position accounts for 0.12% of the portfolio, ranked #50.

Midwest Capital Advisors first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Midwest Capital Advisors held 236 shares of Eli Lilly worth $284K as of Q2 2026.
  • Midwest Capital Advisors left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.12% of Midwest Capital Advisors's portfolio in Q2 2026, its #50 holding.
  • Midwest Capital Advisors first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Midwest Capital Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.